Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers

Cladribine is an oral disease-modifying drug authorized by the European Medicine Agency for the treatment of highly active relapsing multiple sclerosis (MS). To provide real-world evidence of cladribine's effectiveness and safety in people with MS (pwMS). A retrospective observational multi-cen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neuroimmunology 2023-09, Vol.382, p.578164-578164, Article 578164
Hauptverfasser:	Adamec, Ivan, Brecl Jakob, Gregor, Rajda, Cecilia, Drulović, Jelena, Radulović, Ljiljana, Bašić Kes, Vanja, Lazibat, Ines, Rimac, Julija, Cindrić, Igor, Gržinčić, Tihana, Abičić, Ana, Barun, Barbara, Gabelić, Tereza, Gomezelj, Sarah, Mesaroš, Šarlota, Pekmezović, Tatjana, Klivényi, Péter, Krbot Skorić, Magdalena, Habek, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Cladribine Multiple sclerosis Real-world data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!